These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 27131064)
1. Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents. Chen CY; Liu NY; Lin HC; Lee CY; Hung CC; Chang CS Eur J Med Chem; 2016 Aug; 118():219-29. PubMed ID: 27131064 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship study of novel 2-aminobenzofuran derivatives as P-glycoprotein inhibitors. Chen CY; Lin CM; Lin HC; Huang CF; Lee CY; Si Tou TC; Hung CC; Chang CS Eur J Med Chem; 2017 Jan; 125():1023-1035. PubMed ID: 27810590 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors. Hung CC; Chen CY; Wu YC; Huang CF; Huang YC; Chen YC; Chang CS Eur J Med Chem; 2020 Sep; 201():112422. PubMed ID: 32569926 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells. Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037 [TBL] [Abstract][Full Text] [Related]
5. Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression. Liao D; Zhang W; Gupta P; Lei ZN; Wang JQ; Cai CY; Vera AA; Zhang L; Chen ZS; Yang DH Molecules; 2019 Nov; 24(23):. PubMed ID: 31801248 [TBL] [Abstract][Full Text] [Related]
6. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance. Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724 [TBL] [Abstract][Full Text] [Related]
7. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells. Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405 [TBL] [Abstract][Full Text] [Related]
8. The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance. Cao Z; Wright M; Cheng J; Huang X; Liu L; Wu L; Yang P Oncol Rep; 2014 Sep; 32(3):1211-7. PubMed ID: 25017650 [TBL] [Abstract][Full Text] [Related]
9. Zhankuic Acids A, B and C from Teng YN; Wang YH; Wu TS; Hung HY; Hung CC Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766413 [No Abstract] [Full Text] [Related]
10. Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines. Takács D; Csonka Á; Horváth Á; Windt T; Gajdács M; Riedl Z; Hajós G; Amaral L; Molnár J; Spengler G Anticancer Res; 2015 Jun; 35(6):3245-51. PubMed ID: 26026084 [TBL] [Abstract][Full Text] [Related]
11. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin. Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225 [TBL] [Abstract][Full Text] [Related]
12. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related]
13. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169 [TBL] [Abstract][Full Text] [Related]
14. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Xu HB; Li L; Liu GQ Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278 [TBL] [Abstract][Full Text] [Related]
17. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins. Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976 [TBL] [Abstract][Full Text] [Related]
18. Esters of the marine-derived triterpene sipholenol A reverse P-GP-mediated drug resistance. Zhang Y; Zhang YK; Wang YJ; Vispute SG; Jain S; Chen Y; Li J; Youssef DT; El Sayed KA; Chen ZS Mar Drugs; 2015 Apr; 13(4):2267-86. PubMed ID: 25874923 [TBL] [Abstract][Full Text] [Related]
19. Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic. Ma B; Chai S; Li N; To KK; Kan WL; Yang D; Lin G Int J Pharm; 2012 Mar; 424(1-2):33-9. PubMed ID: 22226881 [TBL] [Abstract][Full Text] [Related]
20. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells. Tran TP; Kim HG; Choi JH; Na MK; Jeong HG Phytomedicine; 2013 May; 20(7):622-31. PubMed ID: 23466342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]